🤯 Have you seen our AI stock pickers’ 2024 results? 84.62%! Grab November’s list now.Pick Stocks with AI

Zoetis Inc (ZTS)

NYSE
Currency in USD
181.95
+3.17(+1.77%)
Closed
After Hours
182.01+0.06(+0.03%)
ZTS Scorecard
Full Analysis
Management has been aggressively buying back shares
Earnings results expected today
Fair Value
Day's Range
179.20183.11
52 wk Range
144.80201.92
Prev. Close
181.95
Open
179.98
Day's Range
179.2-183.11
52 wk Range
144.8-201.92
Volume
2,838,633
Average Volume (3m)
1,846,900
1-Year Change
12.16%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
ZTS Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
214.78
Upside
+18.04%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 12 consecutive years
Show more

Zoetis Inc Company Profile

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.

Employees
14100

InvestingPro Research for Zoetis Inc


Market Leader's Edge
Zoetis dominates animal health with robust organic growth and innovative products, showcasing resilience amid economic challenges
Product Powerhouses
Explore Zoetis's key franchises like Librela and Apoquel, driving impressive growth despite market hurdles and competitive pressures
Strategic Expansion
Delve into Zoetis's untapped market potential in Allergy Dermatitis and Pain management, bolstered by a diverse pipeline of next-gen treatments
Financial Forecast
Analysts project steady earnings growth with EPS estimates ranging from $5.79 to $6.48 over two years, and an average price target of $230
Read full SWOT analysis

Compare ZTS to Peers and Sector

Metrics to compare
ZTS
Peers
Sector
Relationship
P/E Ratio
35.2x−3.1x−0.6x
PEG Ratio
4.740.080.00
Price/Book
16.6x1.4x2.6x
Price / LTM Sales
9.2x2.2x3.2x
Upside (Analyst Target)
17.6%63.5%48.6%
Fair Value Upside
Unlock12.8%7.0%Unlock

FAQ

What Is the Zoetis Inc (ZTS) Stock Price Today?

The Zoetis Inc stock price today is 181.95.

What Stock Exchange Does Zoetis Inc Trade On?

Zoetis Inc is listed and trades on the NYSE stock exchange.

What Is the Stock Symbol for Zoetis Inc?

The stock symbol for Zoetis Inc is "ZTS."

Does Zoetis Inc Pay Dividends? What’s The Current Dividend Yield?

The dividend yield is 0.95%.

What Is the Zoetis Inc Market Cap?

As of today, Zoetis Inc market cap is 82.43B.

What is Zoetis Inc Earnings Per Share?

The Zoetis Inc EPS is 5.12.

What Is the Next Zoetis Inc Earnings Date?

Zoetis Inc will release its next earnings report on 03 Nov 2024.

From a Technical Analysis Perspective, Is ZTS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.